deltatrials
Completed NA INTERVENTIONAL 2-arm NCT02858583

SI + CC Versus 3:1 C:V Ratio During Neonatal CPR (SURV1VE)

SURV1VE-Trial - Sustained Inflation and Chest Compression Versus 3:1 Chest Compression to Ventilation Ratio During Cardiopulmonary Resuscitation of Asphyxiated Newborns: A Randomized Controlled Trial

Sponsor: University of Alberta

Interventions 3:1 C:V CC+SI
Updated 18 times since 2017 Last updated: Aug 26, 2024 Started: Oct 19, 2017 Primary completion: Sep 22, 2022 Completion: Sep 22, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Birth Asphyxia and Bradycardia and is currently completed. University of Alberta leads this study, which shows 18 recorded versions since 2017 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jan 2017 – ~Apr 2017 · 3 months · monthly snapshot~Apr 2017 – ~Aug 2017 · 4 months · monthly snapshot~Aug 2017 – ~Nov 2017 · 3 months · monthly snapshot~Nov 2017 – ~Jan 2018 · 2 months · monthly snapshot~Jan 2018 – ~Jun 2018 · 5 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~May 2019 · 9 months · monthly snapshot~May 2019 – ~Dec 2019 · 7 months · monthly snapshot~Dec 2019 – ~Apr 2020 · 4 months · monthly snapshot~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshot~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshot~Oct 2021 – ~Jul 2022 · 9 months · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Mar 2023 · 6 months · monthly snapshot~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

18 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Aug 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jul 2024 — Aug 2024 [monthly]

    Completed NA

  4. Mar 2023 — Jul 2024 [monthly]

    Completed NA

  5. Sep 2022 — Mar 2023 [monthly]

    Completed NA

    Status: RecruitingCompleted

Show 13 earlier versions
  1. Jul 2022 — Sep 2022 [monthly]

    Recruiting NA

  2. Oct 2021 — Jul 2022 [monthly]

    Recruiting NA

  3. Jan 2021 — Oct 2021 [monthly]

    Recruiting NA

  4. Apr 2020 — Jan 2021 [monthly]

    Recruiting NA

  5. Dec 2019 — Apr 2020 [monthly]

    Recruiting NA

  6. May 2019 — Dec 2019 [monthly]

    Recruiting NA

  7. Aug 2018 — May 2019 [monthly]

    Recruiting NA

  8. Jun 2018 — Aug 2018 [monthly]

    Recruiting NA

  9. Jan 2018 — Jun 2018 [monthly]

    Recruiting NA

  10. Nov 2017 — Jan 2018 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  11. Aug 2017 — Nov 2017 [monthly]

    Not Yet Recruiting NA

  12. Apr 2017 — Aug 2017 [monthly]

    Not Yet Recruiting NA

  13. Jan 2017 — Apr 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Alberta
Data source: University of Alberta

For direct contact, visit the study record on ClinicalTrials.gov .